About this Journal Submit a Manuscript Table of Contents
International Journal of Family Medicine
Volume 2011 (2011), Article ID 872638, 7 pages
http://dx.doi.org/10.1155/2011/872638
Research Article

HIV Sexual and Drug-Use Risk in Drug-Dependent Pregnant Patients in Comprehensive Drug Treatment

1RTI International, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA
2Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
3Department of Obstetrics and Gynecology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA
4Department of Psychology, University of Maryland, College Park, MD 20742, USA

Received 3 December 2010; Revised 17 January 2011; Accepted 21 January 2011

Academic Editor: M. Kljakovic

Copyright © 2011 Hendrée E. Jones et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

This secondary analysis study investigated HIV sexual and drug-use risk in drug-dependent pregnant patients over the first month postrandomization to reinforcement-based treatment (RBT) ( 𝑛 = 4 7 ) or usual care (UC) ( 𝑛 = 4 2 ). Analysis of primary outcomes had indicated that RBT participants spent significantly longer time in treatment and recovery housing than UC participants. The present study examined the ability of 9 risk markers—age, race, estimated gestational age at treatment entry, lifetime substance abuse treatment episodes, history of prostitution charges, history of serious depression, current heroin injection status, current housing status, and current partner substance use—to predict changes in HIV risks. Sexual risk declined for participant subgroups with prostitution-charge histories and unstable housing. Drug-use risk declined for heroin injectors and nondepressed participants. A relationship was found between number of lifetime drug treatment episodes and sexual and drug-use risk. The role of risk markers in the response of drug-dependent pregnant women to drug treatment require attention.